Phage therapy at BIOASTER

#PhageTherapy at BIOASTER At @Bioaster, we have developed #preclinicalModels allowing To follow the concentration of #phages over time (#pharmacokinetics) in different fluids and organs after administration by various routes On...

BLOOD-ON-CHIP INITIATIVE

BIOASTER and Institut Pasteur are proud to join forces to build a novel microphysiological system (MPS) mimicking the first steps of immune activation during vaccination. This system will enable studying...

New publication about COVID-19 vaccine on eBioMedicine

The COVID19-101 project in partnership with the Institut Pasteur aimed to characterize the immune response induced by the SARS-CoV-2 vaccine candidate as part of a phase I clinical study. This...

BIOASTER wishes you a healthy & prosperous new year!

BIOASTER wishes you a healthy & prosperous new year! “When the going gets tough, the tough get going” Thanks to our partners, founding members and teams for keeping on building...

BIOASTER is glad to be part of Cynbiome

BIOASTER is glad to be part of Cynbiome, the 1st preclinical excellence research network dedicated to the #microbiome research applied to infectiousdiseases. Together with our partners, we will capitalize on...